Description

[(2R,3S)-2,3-Bis(Acetyloxy)-3-[1-Phenyl-1H-Pyrazolo[3,4-B]Quinoxalin-3-Yl]Propyl]α-D-Galactopyranoside 2,3,4,6-Tetraacetate is a high-purity, complex organic compound with a defined stereochemistry, serving as a critical advanced intermediate in pharmaceutical research and development. Its value lies in its role as a sophisticated building block for the synthesis of novel therapeutic agents, particularly in areas requiring specific glycosidic linkages and heterocyclic frameworks. This product is essential for medicinal chemists and process development scientists in pharmaceutical, biotechnology, and advanced fine chemical sectors who require reliable, high-quality intermediates for drug discovery programs.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly those targeting specific biological pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to develop new therapeutic molecules with optimized efficacy and safety profiles.
• Glycoconjugate Synthesis: Serves as a protected galactose derivative for the development of complex glycoconjugates and carbohydrate-based drugs.
• Heterocyclic Compound Development: The pyrazoloquinoxaline core structure makes it valuable for creating compounds with potential biological activity in oncology and neurology.
• Process Chemistry Scale-Up: Used in the development and optimization of scalable synthetic routes for active pharmaceutical ingredients (APIs).
• Biochemical Probe Development: Can be utilized to create labeled or modified probes for studying biological interactions and mechanisms.

Basic Information

Product Name	[(2R,3S)-2,3-Bis(Acetyloxy)-3-[1-Phenyl-1H-Pyrazolo[3,4-B]Quinoxalin-3-Yl]Propyl]α-D-Galactopyranoside 2,3,4,6-Tetraacetate
CAS No.	33797-01-2
Molecular Formula	C38H38N4O13
Molecular Weight	758.73 g/mol
Synonyms	1-Phenyl-3-[(2R,3S)-2,3-diacetoxy-3-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyloxy)propyl]pyrazolo[3,4-b]quinoxaline; Galactopyranoside derivative, tetraacetate; 1-Phenyl-1H-pyrazolo[3,4-b]quinoxaline-3-propyl galactoside tetraacetate; (2R,3S)-2,3-Diacetoxy-3-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside; Protected galactosyl pyrazoloquinoxaline intermediate; CAS 33797-01-2
EINECS	Contact for details

Quality Control

Our production of [(2R,3S)-2,3-Bis(Acetyloxy)-3-[1-Phenyl-1H-Pyrazolo[3,4-B]Quinoxalin-3-Yl]Propyl]α-D-Galactopyranoside 2,3,4,6-Tetraacetate adheres to stringent quality management systems to ensure batch-to-batch consistency and purity suitable for research and development applications. Each lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your regulatory and quality documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.